FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2748987661> ?p ?o ?g. }

• W2748987661 abstract "Monoclonal antibodies are among the most clinically effective drugs used to treat cancer. However their target repertoire is limited as there are relatively few tumor-specific or tumor-associated cell surface or soluble antigens. Intracellular molecules represent nearly half of the human proteome and provide an untapped reservoir of potential therapeutic targets. Antibodies have been developed to target externalized antigens, have also been engineered to enter into cells or may be expressed intracellularly with the aim of binding intracellular antigens. Furthermore, intracellular proteins can be degraded by the proteasome into short, commonly 8-10 amino acid long, peptides that are presented on the cell surface in the context of major histocompatibility complex class I (MHC-I) molecules. These tumor-associated peptide-MHC-I complexes can then be targeted by antibodies known as T-cell receptor mimic (TCRm) or T-cell receptor (TCR)-like antibodies, which recognize epitopes comprising both the peptide and the MHC-I molecule, similarly to the recognition of such complexes by the TCR on T cells. Advances in the production of TCRm antibodies have enabled the generation of multiple TCRm antibodies, which have been tested in vitro and in vivo, expanding our understanding of their mechanisms of action and the importance of target epitope selection and expression. This review will summarize multiple approaches to targeting intracellular antigens with therapeutic antibodies, in particular describing the production and characterization of TCRm antibodies, the factors influencing their target identification, their advantages and disadvantages in the context of TCR therapies, and the potential to advance TCRm-based therapies into the clinic." @default.
• W2748987661 created "2017-08-31" @default.
• W2748987661 creator A5008969451 @default.
• W2748987661 creator A5040164104 @default.
• W2748987661 creator A5077510125 @default.
• W2748987661 date "2017-08-18" @default.
• W2748987661 modified "2023-10-12" @default.
• W2748987661 title "Therapeutic Antibodies against Intracellular Tumor Antigens" @default.
• W2748987661 cites W1491628483 @default.
• W2748987661 cites W1537178958 @default.
• W2748987661 cites W1551906185 @default.
• W2748987661 cites W1591828451 @default.
• W2748987661 cites W1801598216 @default.
• W2748987661 cites W1826359777 @default.
• W2748987661 cites W1929870640 @default.
• W2748987661 cites W1933510216 @default.
• W2748987661 cites W1934768104 @default.
• W2748987661 cites W1936697213 @default.
• W2748987661 cites W1964187194 @default.
• W2748987661 cites W1964828595 @default.
• W2748987661 cites W1970941056 @default.
• W2748987661 cites W1971620413 @default.
• W2748987661 cites W1975213486 @default.
• W2748987661 cites W1975633473 @default.
• W2748987661 cites W1984678830 @default.
• W2748987661 cites W1986388364 @default.
• W2748987661 cites W1988837817 @default.
• W2748987661 cites W1989634918 @default.
• W2748987661 cites W1995138538 @default.
• W2748987661 cites W2000705595 @default.
• W2748987661 cites W2001400574 @default.
• W2748987661 cites W2001656273 @default.
• W2748987661 cites W2003156803 @default.
• W2748987661 cites W2005504195 @default.
• W2748987661 cites W2006987944 @default.
• W2748987661 cites W2007205086 @default.
• W2748987661 cites W2009179035 @default.
• W2748987661 cites W2011518926 @default.
• W2748987661 cites W2013875806 @default.
• W2748987661 cites W2018012729 @default.
• W2748987661 cites W2019421915 @default.
• W2748987661 cites W2019889336 @default.
• W2748987661 cites W2020398834 @default.
• W2748987661 cites W2022228265 @default.
• W2748987661 cites W2022996046 @default.
• W2748987661 cites W2024877032 @default.
• W2748987661 cites W2026134650 @default.
• W2748987661 cites W2032760352 @default.
• W2748987661 cites W2043080692 @default.
• W2748987661 cites W2044003873 @default.
• W2748987661 cites W2048497409 @default.
• W2748987661 cites W2048706150 @default.
• W2748987661 cites W2049730817 @default.
• W2748987661 cites W2056169996 @default.
• W2748987661 cites W2057542215 @default.
• W2748987661 cites W2057994906 @default.
• W2748987661 cites W2064761355 @default.
• W2748987661 cites W2064888792 @default.
• W2748987661 cites W2065042783 @default.
• W2748987661 cites W2068063168 @default.
• W2748987661 cites W2072822881 @default.
• W2748987661 cites W2073311064 @default.
• W2748987661 cites W2074570972 @default.
• W2748987661 cites W2075856343 @default.
• W2748987661 cites W2075901113 @default.
• W2748987661 cites W2078722792 @default.
• W2748987661 cites W2078936681 @default.
• W2748987661 cites W2079154240 @default.
• W2748987661 cites W2083426921 @default.
• W2748987661 cites W2087493295 @default.
• W2748987661 cites W2087717565 @default.
• W2748987661 cites W2093966230 @default.
• W2748987661 cites W2100258190 @default.
• W2748987661 cites W2116677602 @default.
• W2748987661 cites W2119324245 @default.
• W2748987661 cites W2136498843 @default.
• W2748987661 cites W2140120180 @default.
• W2748987661 cites W2141299652 @default.
• W2748987661 cites W2141609931 @default.
• W2748987661 cites W2142066580 @default.
• W2748987661 cites W2142478072 @default.
• W2748987661 cites W2144265524 @default.
• W2748987661 cites W2147451568 @default.
• W2748987661 cites W2148368831 @default.
• W2748987661 cites W2148727240 @default.
• W2748987661 cites W2149014514 @default.
• W2748987661 cites W2150345297 @default.
• W2748987661 cites W2151412087 @default.
• W2748987661 cites W2152099551 @default.
• W2748987661 cites W2155050260 @default.
• W2748987661 cites W2155589321 @default.
• W2748987661 cites W2156037313 @default.
• W2748987661 cites W2157304416 @default.
• W2748987661 cites W2158562624 @default.
• W2748987661 cites W2158777708 @default.
• W2748987661 cites W2159190300 @default.
• W2748987661 cites W2159414611 @default.
• W2748987661 cites W2160815414 @default.
• W2748987661 cites W2161976254 @default.
• W2748987661 cites W2164835880 @default.

• next